Ken Griffin Fulgent Genetics, Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 28,500 shares of FLGT stock, worth $652,365. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,500

Previous 80,700 64.68%

Holding current value

$652,365

Previous $1.75 Million 68.08%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$19.09 - $22.57 $1.41 Million - $1.67 Million	73,796 Added 65.63%	186,235 $3.65 Million
Q1 2024 May 15, 2024	SELL	$21.55 - $29.29 $225,003 - $305,816	-10,441 Reduced 8.5%	112,439 $2.44 Million
Q4 2023 Feb 14, 2024	SELL	$23.64 - $30.27 $1.66 Million - $2.12 Million	-70,136 Reduced 36.34%	122,880 $3.55 Million
Q3 2023 Nov 14, 2023	SELL	$26.74 - $40.81 $7.26 Million - $11.1 Million	-271,406 Reduced 58.44%	193,016 $5.16 Million
Q2 2023 Aug 14, 2023	BUY	$28.52 - $40.7 $4.74 Million - $6.77 Million	166,247 Added 55.75%	464,422 $17.2 Million
Q1 2023 May 15, 2023	BUY	$29.39 - $36.27 $7.08 Million - $8.74 Million	240,849 Added 420.14%	298,175 $9.31 Million
Q4 2022 Feb 14, 2023	SELL	$29.23 - $40.28 $3.14 Million - $4.33 Million	-107,467 Reduced 65.21%	57,326 $1.71 Million
Q3 2022 Nov 14, 2022	BUY	$37.92 - $63.74 $1.59 Million - $2.68 Million	42,057 Added 34.27%	164,793 $6.28 Million
Q2 2022 Aug 15, 2022	BUY	$47.98 - $62.75 $2.95 Million - $3.86 Million	61,468 Added 100.33%	122,736 $6.69 Million
Q1 2022 May 16, 2022	SELL	$49.85 - $96.11 $8.36 Million - $16.1 Million	-167,624 Reduced 73.23%	61,268 $3.82 Million
Q4 2021 Feb 14, 2022	SELL	$77.3 - $105.0 $2.21 Million - $3 Million	-28,528 Reduced 11.08%	228,892 $23 Million
Q3 2021 Nov 15, 2021	BUY	$74.87 - $110.87 $18.2 Million - $27 Million	243,672 Added 1772.42%	257,420 $23.2 Million
Q2 2021 Aug 16, 2021	SELL	$66.8 - $100.45 $9.67 Million - $14.5 Million	-144,784 Reduced 91.33%	13,748 $1.27 Million
Q1 2021 May 17, 2021	BUY	$59.3 - $183.85 $8.69 Million - $27 Million	146,623 Added 1231.19%	158,532 $15.3 Million
Q4 2020 Feb 16, 2021	BUY	$31.01 - $52.1 $53,430 - $89,768	1,723 Added 16.92%	11,909 $620,000
Q3 2020 Nov 16, 2020	BUY	$15.89 - $50.51 $161,855 - $514,494	10,186 New	10,186 $408,000

Others Institutions Holding FLGT

# of Institutions

195

Shares Held

15.3M

Call Options Held

1.07M

Put Options Held

27.9K

View Full List

About Fulgent Genetics, Inc.

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $693M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

More about FLGT

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account